Article

Orchiectomy as an alternative to injectable therapies as a tool to improve access to new generation systemic treatments for Advanced Prostate Cancer in Developing Countries

2024-05-17

Abstract excerpt

<title>Abstract</title> <p><bold>PURPOSE: </bold>The Brazilian Public Health System (BPHS) hosts approximately 71,730 patients with prostate cancer annually for whom androgen deprivation therapy (ADT) is the is the primary treatment for advanced hormone-sensitive prostate cancer (aHSPC) patients. Androgen receptor pathway inhibitors (ARPIs) are not accessible through the BPHS. Using the BPHS as a model, this stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: db261e19-b80b-5c84-84c7-114b8f030dd2
DOI: 10.21203/rs.3.rs-4363862/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Orchiectomy as an alternative to injectable therapies as a tool to improve access to new generation systemic treatments for Advanced Prostate Cancer in Developing CountriesDOI 10.21203/rs.3.rs-4363862/v1Read

Advanced prostate cancer management by urologist: a real-life national survey in BrazilSemantic proximity Read

What is the current status of metastatic prostate cancer in Colombia? A retrospective study based on publicly available state databasesSemantic proximity Read

Prostate cancer treatment – China's perspectiveSemantic proximity Read

Impact of the COVID-19 Pandemic on Prostate Cancer Diagnosis, Staging, and Treatment: A Population-Based Study in Northern ItalySemantic proximity Read

Results of ATOMS (Adjustable Trans-Obturator Male System) in Patients with Prostate Cancer treated with Prostatectomy and Radiotherapy: A Multicenter StudySemantic proximity Read

Modified Local Anesthesia for Transperineal Prostate Biopsy: A Comparative Study of Safety and TolerabilitySemantic proximity Read

Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.Semantic proximity Read

Ixeris polycephala extract alleviates progression of benign prostatic hyperplasia in ratsSemantic proximity Read

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trialSemantic proximity Read

Learning From the 'Tail End' of De-implementation: The Case of Chemical Castration for Localized Prostate CancerSemantic proximity Read

Navigate: A study protocol for a randomized controlled trial of an online treatment decision aid for men with low risk prostate cancer and their partnersSemantic proximity Read

Cost-effectiveness of talazoparib plus enzalutamide as first-line therapy in metastatic castration-resistant prostate cancerSemantic proximity Read